Why Segro's Board Finally Backed Prologis: A £14bn Choice Between Now and Maybe-Maybe Not

Why Segro's unanimous recommendation changed the debate

Segro's board has moved from rejecting earlier bids to recommending this latest one.

That is not mere housekeeping. In the UK, a "unanimously concluded" recommendation given in a City Code on Takeovers and Mergers context is a clear signal that the directors are willing to back the deal publicly. After turning down earlier approaches, that shift tells shareholders the board now believes the proposal is worth endorsing.

What Prologis is offering

Prologis' latest proposal puts around £13.5bn on the table: 0.0890 new Prologis shares per Segro share, plus a partial cash alternative worth up to £2.7bn. That gives shareholders something concrete to assess. Accept the offer, and some investors can take cash now while others take listed shares in the combined business. Reject it, and the case for holding out has to be stronger than the premium on offer today.

Why the timing matters

The decision also came after Prologis said earlier talks did not provide meaningful clarity on how Segro could justify moving forward. That sharpens the choice: shareholders are no longer weighing two equally plausible futures. They are weighing a current offer against a standalone case that still needs to be proved.

Why the board's resistance weakened

The premium became harder to dismiss

Prologis' revised pitch included a 9.7% premium to pro forma adjusted NAV. For a property company, that is a meaningful reference point because it ties the bid to asset value rather than only to share-price history. In that sense, the offer looked less like a negotiating opening and more like a real uplift shareholders could take now.

The standalone case looked less concrete

Prologis also challenged Segro's aspirational valuation and said discussions had not clarified a path to recommendation. If that assessment is accepted, the board would be asking shareholders to give up a live offer in favour of a future value case that has not been independently verified. That is a harder position to defend once the market is focused on the premium being offered today.

The independence question was relatively clean

Segro's disclosure showed no obvious side arrangements that would muddy the board's stance. The company said its directors had 0.09% of the share capital and that there were no indemnity or option arrangements tied to the offer, nor formal or informal arrangements around voting or future disposals. That does not guarantee the directors are thinking exactly like outside shareholders, but it does mean the independence issue was not the main focus of the debate.

What the recommendation does not do

A "unanimously concluded" recommendation carries weight, but it does not close the deal. Prologis has said the announcement was not a firm intention to make an offer, and it has stated there is no certainty that any firm offer will be made.

So the board's change of position matters a lot, but it does not settle the value debate.

What investors should watch before the next step

Prologis still has until 5pm on 12 August to go formal. Because this would be one of the largest foreign takeovers of a UK-listed company, that wait is important. A board recommendation can help anchor the market around the premium, but investors still need a firm offer to make the transaction more than a promising setup.

Why the deal mechanics still matter

The consideration is largely share-based, so the final payout depends on Prologis' share price through the process as much as on the headline premium. On full cash take-up, existing Segro shareholders would own around 9.2% of the enlarged Prologis. If Prologis holds its value, that supports the case for the offer. If not, the practical economics for shareholders weaken.

The key question from here

The next step is straightforward: does Prologis convert this into a firm offer, and does the pricing remain competitive when it does? Until that happens, Segro shareholders are being asked to judge whether the current premium is attractive enough to endorse - not whether the final deal is certain.